Takeda Pharmaceutical Company Limited (BVMF:TAKP34)

BVMF:TAKP34 Revenue

Takeda Pharmaceutical Company had revenue of 1.11T JPY in the quarter ending September 30, 2025, a decrease of -5.38%. This brings the company's revenue in the last twelve months to 4.47T, down -4.95% year-over-year. In the fiscal year ending March 31, 2025, Takeda Pharmaceutical Company had annual revenue of 4.58T with 7.45% growth.

• Revenue (ttm): 4.47T JPY
• Revenue Growth: -4.95%
• P/S Ratio: 1.71
• Revenue / Employee: 94.20M JPY
• Employees: 47,455
• Market Cap: 271.85B BRL

Revenue Chart

* This company reports financials in JPY.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2025	4.58T	317.79B	7.45%
Mar 31, 2024	4.26T	236.28B	5.87%
Mar 31, 2023	4.03T	458.47B	12.85%
Mar 31, 2022	3.57T	371.19B	11.61%
Mar 31, 2021	3.20T	-93.38B	-2.84%
Mar 31, 2020	3.29T	1.19T	56.93%
Mar 31, 2019	2.10T	326.69B	18.45%
Mar 31, 2018	1.77T	38.48B	2.22%
Mar 31, 2017	1.73T	-75.33B	-4.17%
Mar 31, 2016	1.81T	29.55B	1.66%
Mar 31, 2015	1.78T	86.14B	5.09%
Mar 31, 2014	1.69T	134.68B	8.65%
Mar 31, 2013	1.56T	-	-